An action plan for pan-European defence against new SARS-CoV-2 variants.
作者信息
Priesemann Viola, Balling Rudi, Brinkmann Melanie M, Ciesek Sandra, Czypionka Thomas, Eckerle Isabella, Giordano Giulia, Hanson Claudia, Hel Zdenek, Hotulainen Pirta, Klimek Peter, Nassehi Armin, Peichl Andreas, Perc Matjaz, Petelos Elena, Prainsack Barbara, Szczurek Ewa
机构信息
Max-Planck-Institute for Dynamics and Self-Organization, 37077 Göttingen, Germany.
University of Luxembourg, Luxembourg, Luxembourg.
出版信息
Lancet. 2021 Feb 6;397(10273):469-470. doi: 10.1016/S0140-6736(21)00150-1. Epub 2021 Jan 21.
Abstract
摘要
相似文献
1
An action plan for pan-European defence against new SARS-CoV-2 variants.泛欧洲防御新型SARS-CoV-2变体的行动计划。
Lancet. 2021 Feb 6;397(10273):469-470. doi: 10.1016/S0140-6736(21)00150-1. Epub 2021 Jan 21.
2
Pfizer COVID vaccine protects against worrying coronavirus variants.辉瑞新冠疫苗可预防令人担忧的新冠病毒变种。
Nature. 2021 May;593(7859):325-326. doi: 10.1038/d41586-021-01222-5.
3
Europe must come together to confront omicron.欧洲必须团结起来应对奥密克戎毒株。
BMJ. 2022 Jan 12;376:o90. doi: 10.1136/bmj.o90.
4
COVID-19 evolution during the pandemic - Implications of new SARS-CoV-2 variants on disease control and public health policies.大流行期间的COVID-19演变——新型SARS-CoV-2变体对疾病控制和公共卫生政策的影响。
Virulence. 2021 Dec;12(1):507-508. doi: 10.1080/21505594.2021.1877066.
5
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.癌症患者中的 COVID-19：临床特征和结局——LEOSS 登记处的分析。
Ann Hematol. 2021 Feb;100(2):383-393. doi: 10.1007/s00277-020-04328-4. Epub 2020 Nov 7.
6
Public health actions to control new SARS-CoV-2 variants.公共卫生措施以控制新型 SARS-CoV-2 变异株。
Cell. 2021 Mar 4;184(5):1127-1132. doi: 10.1016/j.cell.2021.01.044. Epub 2021 Jan 29.
7
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.2020 年夏 SARS-CoV-2 变异株在欧洲的传播。
Nature. 2021 Jul;595(7869):707-712. doi: 10.1038/s41586-021-03677-y. Epub 2021 Jun 7.
8
What have we learnt so far from COVID-19?迄今为止，我们从 COVID-19 中学到了什么？
Nat Rev Immunol. 2021 Feb;21(2):67-68. doi: 10.1038/s41577-021-00498-y.
9
From COVID-19 to COVID-20: One Virus, Two Diseases.从新冠病毒到“新冠20”：一种病毒，两种疾病。
Disaster Med Public Health Prep. 2020 Dec;14(6):e18-e20. doi: 10.1017/dmp.2020.363. Epub 2020 Oct 6.
10
Misinformation Dissemination in Twitter in the COVID-19 Era.新冠疫情时代推特上的错误信息传播
Am J Med. 2020 Dec;133(12):1367-1369. doi: 10.1016/j.amjmed.2020.07.012. Epub 2020 Aug 14.
引用本文的文献
1
The Role of NEU1 in Coronavirus Infection and Pathogenesis.NEU1在冠状病毒感染与发病机制中的作用。
Virol Immunol J. 2024;8(3). doi: 10.23880/vij-16000351. Epub 2024 Aug 8.
2
Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study.受体相互作用蛋白激酶 1（RIPK1）抑制剂 eclitasertib（SAR443122）在重症 COVID-19 患者中的免疫调节和临床疗效：一项 1b 期、随机、双盲、安慰剂对照研究。
Respir Res. 2024 Feb 28;25(1):107. doi: 10.1186/s12931-024-02670-z.
3
Development of Rapid Aptamer-Based Screening Assay for the Detection of Covid-19 Variants.用于检测新冠病毒变体的基于适配体的快速筛选检测方法的开发。
ACS Omega. 2023 Aug 31;8(36):32877-32883. doi: 10.1021/acsomega.3c04137. eCollection 2023 Sep 12.
4
From emergency response to long-term management: the many faces of the endemic state of COVID-19.从应急响应到长期管理：新冠疫情流行状态的多面性
Lancet Reg Health Eur. 2023 May 26;30:100664. doi: 10.1016/j.lanepe.2023.100664.
5
Comprehensive mutation profiling from wastewater in southern Germany extends evidence of circulating SARS-CoV-2 diversity beyond mutations characteristic for Omicron.德国南部废水中的全面突变分析扩展了新冠病毒（SARS-CoV-2）传播多样性的证据，其范围超出了奥密克戎的特征性突变。
FEMS Microbes. 2023 Mar 3;4:xtad006. doi: 10.1093/femsmc/xtad006. eCollection 2023.
6
SERS Signature of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs: Towards Perspective COVID-19 Point-of-Care Diagnostics.唾液和鼻咽拭子中 SARS-CoV-2 的 SERS 特征：迈向有前景的 COVID-19 即时诊断。
Int J Mol Sci. 2023 Jun 3;24(11):9706. doi: 10.3390/ijms24119706.
7
Targeting intracellular Neu1 for coronavirus infection treatment.靶向细胞内Neu1用于冠状病毒感染治疗。
iScience. 2023 Feb 17;26(2):106037. doi: 10.1016/j.isci.2023.106037. Epub 2023 Jan 24.
8
AI in Combating the COVID-19 Pandemic.人工智能助力抗击新冠疫情。
IEEE Intell Syst. 2022 May 20;37(2):3-13. doi: 10.1109/MIS.2022.3164313. eCollection 2022 Mar.
9
Describing a landscape we are yet discovering.描绘一片我们仍在探索的风景。
Adv Stat Anal. 2022;106(3):399-402. doi: 10.1007/s10182-022-00449-5. Epub 2022 Jun 9.
10
Mutation induced infection waves in diseases like COVID-19.突变引发的传染病波，如 COVID-19。
Sci Rep. 2022 Jun 10;12(1):9641. doi: 10.1038/s41598-022-13137-w.
本文引用的文献
1
Could new COVID variants undermine vaccines? Labs scramble to find out.新冠病毒新变种会削弱疫苗效力吗？各实验室竞相展开研究。
Nature. 2021 Jan;589(7841):177-178. doi: 10.1038/d41586-021-00031-0.
2
Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections.呼吁全欧洲共同致力于迅速且持续地减少新冠病毒感染。
Lancet. 2021 Jan 9;397(10269):92-93. doi: 10.1016/S0140-6736(20)32625-8. Epub 2020 Dec 18.
3
Scientific consensus on the COVID-19 pandemic: we need to act now.关于新冠疫情的科学共识：我们现在需要采取行动。
Lancet. 2020 Oct 31;396(10260):e71-e72. doi: 10.1016/S0140-6736(20)32153-X. Epub 2020 Oct 15.
Zotero 插件